Sub menu

Vaccines

Mérieux Inactivated Rabies Vaccine

Details for Mérieux Inactivated Rabies Vaccine and its components.

Recently added

This page was added on 04 June 2018.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Vaccine group
Rabies vaccines
Description:

Registered for use in people of any age.

HDCV — human diploid cell vaccine

Lyophilised powder in a monodose vial with 1.0 mL distilled water as diluent.

Each 1.0 mL reconstituted dose contains:

  • ≥2.5 IU inactivated rabies virus
  • 100–150 µg neomycin
  • ≤70 mg human serum albumin
  • traces of phenol red (indicator)

May contain traces of:

  • bovine gelatin
  • β-propiolactone

For Product Information and Consumer Medicine Information about Mérieux Inactivated Rabies Vaccine visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
Rabies and other lyssaviruses

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/merieux-inactivated-rabies-vaccine

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.